Private Advisor Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Private Advisor Group, LLC

$15.6 Billion
Q3 2024

A detailed history of Private Advisor Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 5,361 shares of REGN stock, worth $4.02 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,361

Previous 5,058 5.99%

Holding current value

$4.02 Million

Previous $5.32 Million 6.0%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$1024.09 - $1201.76 $310,299 - $364,133	303 Added 5.99%	5,361 $5.64 Million
Q2 2024 Aug 05, 2024	BUY	$883.2 - $1071.19 $312,652 - $379,201	354 Added 7.53%	5,058 $5.32 Million
Q1 2024 Apr 30, 2024	SELL	$902.69 - $993.35 $162,484 - $178,803	-180 Reduced 3.69%	4,704 $4.53 Million
Q4 2023 Feb 06, 2024	SELL	$775.18 - $881.7 $44,960 - $51,138	-58 Reduced 1.17%	4,884 $4.29 Million
Q3 2023 Nov 02, 2023	BUY	$692.45 - $844.37 $494,409 - $602,880	714 Added 16.89%	4,942 $4.07 Million
Q2 2023 Aug 09, 2023	BUY	$700.03 - $830.35 $279,311 - $331,309	399 Added 10.42%	4,228 $3.04 Million
Q1 2023 May 10, 2023	BUY	$680.49 - $826.97 $144,263 - $175,317	212 Added 5.86%	3,829 $3.15 Million
Q4 2022 Jan 18, 2023	SELL	$705.89 - $766.39 $65,647 - $71,274	-93 Reduced 2.51%	3,617 $0
Q3 2022 Oct 14, 2022	SELL	$573.97 - $724.32 $1.81 Million - $2.28 Million	-3,145 Reduced 45.88%	3,710 $2.56 Million
Q2 2022 Jul 13, 2022	SELL	$548.35 - $738.84 $862,554 - $1.16 Million	-1,573 Reduced 18.66%	6,855 $4.05 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $2.05 Million - $2.41 Million	-3,447 Reduced 29.03%	8,428 $5.89 Million
Q4 2021 Feb 10, 2022	SELL	$543.48 - $670.97 $4.6 Million - $5.68 Million	-8,471 Reduced 41.63%	11,875 $7.5 Million
Q3 2021 Oct 14, 2021	BUY	$574.03 - $680.96 $1.69 Million - $2.01 Million	2,948 Added 16.94%	20,346 $12.3 Million
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $801,396 - $946,725	1,695 Added 10.79%	17,398 $9.72 Million
Q1 2021 Apr 22, 2021	BUY	$446.73 - $548.2 $2.34 Million - $2.88 Million	5,246 Added 50.17%	15,703 $7.43 Million
Q4 2020 Apr 01, 2021	BUY	$478.3 - $607.98 $592,613 - $753,287	1,239 Added 13.44%	10,457 $5.05 Million
Q3 2020 Nov 02, 2020	BUY	$544.75 - $658.21 $1.18 Million - $1.43 Million	2,167 Added 30.73%	9,218 $5.34 Million
Q2 2020 Aug 17, 2020	BUY	$493.32 - $643.92 $621,583 - $811,339	1,260 Added 21.76%	7,051 $4.4 Million
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $53,116 - $78,119	158 Added 2.8%	5,791 $2.83 Million
Q4 2019 Feb 10, 2020	BUY	$274.13 - $376.51 $60,308 - $82,832	220 Added 4.06%	5,633 $2.12 Million
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $622,394 - $724,655	2,276 Added 72.55%	5,413 $1.5 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $61,118 - $84,623	-204 Reduced 6.11%	3,137 $982,000
Q1 2019 May 13, 2019	SELL	$372.08 - $439.57 $133,576 - $157,805	-359 Reduced 9.7%	3,341 $1.37 Million
Q4 2018 Feb 11, 2019	BUY	$335.82 - $403.04 $5,708 - $6,851	17 Added 0.46%	3,700 $1.38 Million
Q3 2018 Nov 01, 2018	SELL	$351.14 - $408.51 $29,495 - $34,314	-84 Reduced 2.23%	3,683 $1.49 Million
Q2 2018 Aug 09, 2018	BUY	$284.6 - $344.99 $223,695 - $271,162	786 Added 26.37%	3,767 $1.32 Million
Q1 2018 May 09, 2018	SELL	$315.82 - $393.78 $156,646 - $195,314	-496 Reduced 14.27%	2,981 $1.03 Million
Q4 2017 Feb 07, 2018	SELL	$358.63 - $469.95 $328,505 - $430,474	-916 Reduced 20.85%	3,477 $1.3 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $68,589 - $80,136	159 Added 3.76%	4,393 $2.06 Million
Q2 2017 Aug 10, 2017	BUY	N/A	4,234	4,234 $2.12 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account

Private Advisor Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History